CD40 amplifies Fas-mediated apoptosis: a mechanism contributing to emphysema.

Excessive apoptosis and prolonged inflammation of alveolar cells are associated with the pathogenesis of pulmonary emphysema. We aimed to determine whether CD40 affects alveolar epithelial cells and endothelial cells, with regard to evoking apoptosis and inflammation. Mice were repeatedly treated with agonistic-anti CD40 antibody (Ab), with or without agonistic-anti Fas Ab, and evaluated for apoptosis and inflammation in lungs. Human pulmonary microvascular endothelial cells and alveolar epithelial cells were treated with agonistic anti-CD40 Ab and/or anti-Fas Ab to see their direct effect on apoptosis and secretion of proinflammatory molecules in vitro. Furthermore, plasma soluble CD40 ligand (sCD40L) level was evaluated in patients with chronic obstructive pulmonary disease (COPD). In mice, inhaling agonistic anti-CD40 Ab induced moderate alveolar enlargement. CD40 stimulation, in combination with anti-Fas Ab, induced significant emphysematous changes and increased alveolar cell apoptosis. CD40 stimulation also enhanced IFN-γ-mediated emphysematous changes, not via apoptosis induction, but via inflammation with lymphocyte accumulation. In vitro, Fas-mediated apoptosis was enhanced by CD40 stimulation and IFN-γ in endothelial cells and by CD40 stimulation in epithelial cells. CD40 stimulation induced secretion of CCR5 ligands in endothelial cells, enhanced with IFN-γ. Plasma sCD40L levels were significantly increased in patients with COPD, inversely correlating to the percentage of forced expiratory volume in 1 s and positively correlating to low attenuation area score by CT scan, regardless of smoking history. Collectively CD40 plays a contributing role in the development of pulmonary emphysema by sensitizing Fas-mediated apoptosis in alveolar cells and increasing the secretion of proinflammatory chemokines.

[1]  D. Mukhopadhyay,et al.  Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. , 2000, Blood.

[2]  I. Adcock,et al.  Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction , 2008, European Respiratory Journal.

[3]  W. Daniel,et al.  Upregulation of CD40-CD40 Ligand (CD154) in Patients With Acute Cerebral Ischemia , 2003, Stroke.

[4]  N. Ogawa,et al.  Novel role of CD40 in Fas-dependent apoptosis of cultured salivary epithelial cells from patients with Sjögren's syndrome. , 2005, Arthritis and rheumatism.

[5]  Michael P. Brown,et al.  CD40 Ligand (CD154) Enhances the Th1 and Antibody Responses to Respiratory Syncytial Virus in the BALB/c Mouse , 2000, The Journal of Immunology.

[6]  D. Newby,et al.  Upregulation of the CD40/CD40 Ligand Dyad and Platelet-Monocyte Aggregation in Cigarette Smokers , 2004, Circulation.

[7]  Theresa M. Ames,et al.  Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary disease. , 2009, American journal of respiratory and critical care medicine.

[8]  N. Fazal.  OX62+OX6+OX35+ rat dendritic cells are unable to prime CD4+ T cells for an effective immune response following acute burn injury. , 2013, Results in immunology.

[9]  N. Van Rooijen,et al.  Depletion of resident alveolar macrophages does not prevent Fas-mediated lung injury in mice. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[10]  J. Banchereau,et al.  CD40 ligand stimulates proinflammatory cytokine production by human endothelial cells. , 1997, Journal of immunology.

[11]  J. V. Sarma,et al.  Relationship of acute lung inflammatory injury to Fas/FasL system. , 2005, The American journal of pathology.

[12]  Wei Liu,et al.  Role of CCR5 in IFN-γ–induced and cigarette smoke–induced emphysema , 2005 .

[13]  S. Frøland,et al.  Soluble CD40 Ligand in Pulmonary Arterial Hypertension: Possible Pathogenic Role of the Interaction Between Platelets and Endothelial Cells , 2004, Circulation.

[14]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[15]  R. Homer,et al.  Interferon γ Induction of Pulmonary Emphysema in the Adult Murine Lung , 2000, The Journal of experimental medicine.

[16]  P. Barnes.  Immunology of asthma and chronic obstructive pulmonary disease , 2008, Nature Reviews Immunology.

[17]  M. Tagawa,et al.  T-cell-dependent antitumor effects produced by CD40 ligand expressed on mouse lung carcinoma cells are linked with the maturation of dendritic cells and secretion of a variety of cytokines , 2003, Cancer Gene Therapy.

[18]  P. Hirth,et al.  Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. , 2000, The Journal of clinical investigation.

[19]  D. Schwartz,et al.  Chronic LPS inhalation causes emphysema-like changes in mouse lung that are associated with apoptosis. , 2008, American journal of respiratory cell and molecular biology.

[20]  R. Pauwels,et al.  Time course of cigarette smoke-induced pulmonary inflammation in mice , 2005, European Respiratory Journal.

[21]  D. Adams,et al.  CD40 Activation Induces Apoptosis in Cultured Human Hepatocytes via Induction of Cell Surface Fas Ligand Expression and Amplifies Fas-mediated Hepatocyte Death during Allograft Rejection , 1999, The Journal of experimental medicine.

[22]  Min Zhang,et al.  A model of chronic inflammation and pulmonary emphysema after multiple ozone exposures in mice. , 2011, American journal of physiology. Lung cellular and molecular physiology.

[23]  N. Kleiman,et al.  Soluble CD40 ligand in acute coronary syndromes. , 2003, The New England journal of medicine.

[24]  T. Watanabe,et al.  Expression and function of Fas during differentiation and activation of B cells. , 1999, International reviews of immunology.

[25]  A. Churg,et al.  Tumor Necrosis Factor-α Drives 70% of Cigarette Smoke–induced Emphysema in the Mouse , 2004 .

[26]  J. Freedman,et al.  Hypoxia influences CD40-CD40L mediated inflammation in endothelial and monocytic cells. , 2009, Immunology letters.

[27]  R. Flavell,et al.  The Role of CD40 Ligand in Costimulation and T‐Cell Activation , 1996, Immunological reviews.

[28]  S. Nagata,et al.  Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. , 1999, The Journal of clinical investigation.

[29]  T. Nakayama,et al.  Attenuation of lung inflammation and fibrosis in CD69-deficient mice after intratracheal bleomycin , 2011, Respiratory research.

[30]  G. Joos,et al.  Chronic Obstructive Pulmonary Disease 1 New insights into the immunology of chronic obstructive pulmonary disease , 2011 .

[31]  A. Churg,et al.  Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse. , 2004, American journal of respiratory and critical care medicine.

[32]  Janet S. Lee,et al.  Fas-Mediated Acute Lung Injury Requires Fas Expression on Nonmyeloid Cells of the Lung1 , 2005, The Journal of Immunology.

[33]  David Steven Scott,et al.  Activation-induced cell death in B lymphocytes , 2000, Cell Research.

[34]  K. Nishigaki,et al.  An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD. , 1998, Respiratory medicine.

[35]  B. Han,et al.  Cardiovascular , Pulmonary and Renal Pathology Functions of Type II Pneumocyte-Derived Vascular Endothelial Growth Factor in Alveolar Structure , Acute Inflammation , and Vascular Permeability , 2010 .

[36]  Christopher M Waters,et al.  Epithelial repair mechanisms in the lung. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[37]  J. Maurer.  Systemic Inflammation and COPD: The Framingham Heart Study , 2009 .

[38]  F. Bucchieri,et al.  CD40 ligation protects bronchial epithelium against oxidant-induced caspase-independent cell death. , 2006, American journal of respiratory cell and molecular biology.

[39]  H. Shirasawa,et al.  Association of tumor necrosis factor-alpha gene promoter polymorphism with low attenuation areas on high-resolution CT in patients with COPD. , 2002, Chest.

[40]  Y. Oh,et al.  Bone marrow cells repair cigarette smoke-induced emphysema in rats. , 2011, American journal of physiology. Lung cellular and molecular physiology.

[41]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[42]  G. Laszlo,et al.  Computed tomography in pulmonary emphysema. , 1982, Clinical radiology.

[43]  K. Aoshiba,et al.  Alveolar wall apoptosis causes lung destruction and emphysematous changes. , 2003, American journal of respiratory cell and molecular biology.

[44]  S. Yasumura,et al.  Circulating levels of soluble Fas ligand and soluble Fas in patients with chronic obstructive pulmonary disease. , 2000, Respiratory medicine.